Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy
Open Access
Abstract
BACKGROUND: Premenopausal women undergoing chemotherapy are at risk for amenorrhea and impaired fertility. The objective of the current study was to assess levels of mullerian inhibitory substance (MIS), estradiol (E2), follicle‐stimulating hormone (FSH), and menstrual status, in women undergoing chemotherapy. METHODS: A nested prospective cohort study was conducted in women aged P > .05). Serum MIS decreased significantly at 6 weeks and remained suppressed for 52 weeks. E2 levels decreased, and FSH levels increased during chemotherapy; however, at 52 weeks, the levels returned to baseline. At 52 weeks, only 1 patient had MIS above the lower normal range, 15 had return of menstrual function, 11 had premenopausal levels of FSH, and 13 had follicular phase levels of E2. In women aged 35 years, 50% were amenorrheic. Amenorrheic and menstruating women were found to have similar MIS values at baseline and follow‐up. CONCLUSIONS: In young women with BC, chemotherapy decreases MIS rapidly and dramatically. Rapid reductions in MIS do not appear to be predictive of subsequent menstrual function. Ovarian reserve and endocrine function may be affected differently by chemotherapy. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 23 references indexed in Scilit:
- Preservation of Fertility in Patients with CancerNew England Journal of Medicine, 2009
- Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast CancerJournal of Clinical Oncology, 2008
- The role of mullerian inhibiting substance in female reproductionCurrent Opinion in Obstetrics and Gynecology, 2008
- Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignanciesHuman Reproduction, 2008
- Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VIEuropean Journal of Cancer, 2007
- Predictors of ovarian reserve in young women with breast cancerBritish Journal of Cancer, 2007
- Fertility- and Menopause-Related Information Needs of Younger Women With a Diagnosis of Early Breast CancerJournal of Clinical Oncology, 2005
- Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal studyFertility and Sterility, 2005
- Web-Based Survey of Fertility Issues in Young Women With Breast CancerJournal of Clinical Oncology, 2004
- Fertility preservation in female patientsHuman Reproduction Update, 2004